170 related articles for article (PubMed ID: 4153810)
1. Studies on new beta-adrenergic blocking agents. II. Syntheses and pharmacology of 2-anilinotropone derivatives.
Sato Y; Tanaka T; Kumakura S; Koike H; Oshima T
Chem Pharm Bull (Tokyo); 1974 Mar; 22(3):514-22. PubMed ID: 4153810
[No Abstract] [Full Text] [Related]
2. Studies on agents with vasodilator and beta-blocking activities. I.
Seki T; Takezaki T; Ohuchi R; Ohuyabu H; Ishimori T; Yasuda K
Chem Pharm Bull (Tokyo); 1994 Aug; 42(8):1609-16. PubMed ID: 7954913
[TBL] [Abstract][Full Text] [Related]
3. Studies on agents with vasodilator and beta-blocking activities. IV.
Seki T; Nakao T; Masuda T; Hasumi K; Gotanda K; Ishimori T; Honma S; Minami N; Shibata K; Yasuda K
Chem Pharm Bull (Tokyo); 1996 Nov; 44(11):2061-9. PubMed ID: 8945771
[TBL] [Abstract][Full Text] [Related]
4. An approach to peripheral vasodilator-beta-adrenergic blocking agents.
Baldwin JJ; Hirschmann R; Lumma PK; Lumma WC; Ponticello GS; Sweet CS; Scriabine A
J Med Chem; 1977 Aug; 20(8):1024-9. PubMed ID: 19628
[TBL] [Abstract][Full Text] [Related]
5. Studies on agents with vasodilator and beta-blocking activities. III. Synthesis and activity of optical isomers of TZC-1370.
Seki T; Takezaki T; Ohuchi R; Saitoh M; Ishimori T; Yasuda K
Chem Pharm Bull (Tokyo); 1995 Oct; 43(10):1719-23. PubMed ID: 8536346
[TBL] [Abstract][Full Text] [Related]
6. Changes in beta-adrenoceptor-blocking activity produced by chemical modifications in the practolol molecule.
Weinstock M; Schechter Y; Erez M; Shtacher G
Eur J Pharmacol; 1974 May; 26(2):191-7. PubMed ID: 4152806
[No Abstract] [Full Text] [Related]
7. Heterocyclic analogues of the antihypertensive beta-adrenergic blocking agent (S)-2-[3-(ter-butylamino)-2-hydroxypropoxy]-3-cyanopyridine.
Baldwin JJ; Engelhardt EL; Hirschmann R; Ponticello GS; Atkinson JG; Wasson BK; Sweet CS; Scriabine A
J Med Chem; 1980 Jan; 23(1):65-70. PubMed ID: 6102151
[TBL] [Abstract][Full Text] [Related]
8. Anti-hypertension effect of vanylidilol: a phenylaldehyde alpha/beta-adrenoceptor blocker with endothelium-dependent and K+ channels opening-associated vasorelaxant activities.
Chiu CC; Wu JR; Lee CH; Liou SF; Dai ZK; Chen IJ; Yeh JL
Pharmacology; 2004 Mar; 70(3):140-51. PubMed ID: 14752234
[TBL] [Abstract][Full Text] [Related]
9. Antihypertensive and adrenergic receptor blocking properties of the enantiomers of medroxalol.
Cheng HC; Reavis OK; Grisar JM; Claxton GP; Weiner DL; Woodward JK
Life Sci; 1980 Dec 22-29; 27(25-26):2529-34. PubMed ID: 6111723
[No Abstract] [Full Text] [Related]
10. Symbiotic approach to drug design: antihypertensive beta-adrenergic blocking agents.
Baldwin JJ; Lumma WC; Lundell GF; Ponticello GS; Raab AW; Engelhardt EL; Hirschmann R; Sweet CS; Scriabine A
J Med Chem; 1979 Nov; 22(11):1284-90. PubMed ID: 42797
[No Abstract] [Full Text] [Related]
11. Beta-Adrenergic blocking agents. Nitrogen heteroaryl-substituted 2-propanolamines and ethanolamines.
Meyer RF; Stratton CD; Hastings SG; Corey RM
J Med Chem; 1973 Oct; 16(10):113-6. PubMed ID: 4147942
[No Abstract] [Full Text] [Related]
12. Studies on agents with vasodilator and beta-blocking activities. II.
Seki T; Takezaki T; Ohuchi R; Ohuyabu H; Tanimoto Y; Yamaguchi T; Saitoh M; Ishimori T; Yasuda K
Chem Pharm Bull (Tokyo); 1995 Feb; 43(2):247-55. PubMed ID: 7728931
[TBL] [Abstract][Full Text] [Related]
13. -Adrenergic blocking agents of the chromone and xanthone groups. II. Propranolol type derivatives.
Da Re P; Primofiore GP; Bertelli A
J Med Chem; 1972 Aug; 15(8):868-9. PubMed ID: 4402954
[No Abstract] [Full Text] [Related]
14. beta-Adrenergic blocking agents with acute antihypertensive activity.
Baldwin JJ; Engelhardt EL; Hirschmann R; Lundell GF; Ponticello GS; Ludden CT; Sweet CS; Scriabine A; Share NN; Hall R
J Med Chem; 1979 Jun; 22(6):687-94. PubMed ID: 37337
[TBL] [Abstract][Full Text] [Related]
15. Vanidilol: a vanilloid-type vasorelaxant and ocular hypotensive beta-adrenoceptor blocker with partial beta-2-agonist activity.
Sheu MM; Wu BN; Ho WC; Hong SJ; Chen SJ; Lin YT; Chen IJ
Pharmacology; 1997 Apr; 54(4):211-24. PubMed ID: 9211567
[TBL] [Abstract][Full Text] [Related]
16. Design and synthesis of a series of combined vasodilator/beta-adrenoceptor antagonists based on 6-arylpyridazinones.
Slater RA; Howson W; Swayne GT; Taylor EM; Reavill DR
J Med Chem; 1988 Feb; 31(2):345-51. PubMed ID: 2892934
[TBL] [Abstract][Full Text] [Related]
17. Studies on agents with vasodilator and beta-blocking activities. V. Synthesis and pharmacological activity of the optical isomers of TZC-5665.
Seki T; Kanada A; Nakao T; Shiraiwa M; Asano H; Miyazawa K; Ishimori T; Minami N; Shibata K; Yasuda K
Chem Pharm Bull (Tokyo); 1998 Jan; 46(1):84-96. PubMed ID: 9468640
[TBL] [Abstract][Full Text] [Related]
18. Vasoactive and beta-adrenoceptor blocking properties of 3,4-dihydro-8-(2-hydroxy-3-isopropylamino) propoxy-3-nitroxy-2H-1-benzopyran (K-351), a new antihypertensive agent.
Uchida Y; Nakamura M; Shimizu S; Shirasawa Y; Fujii M
Arch Int Pharmacodyn Ther; 1983 Mar; 262(1):132-49. PubMed ID: 6135395
[TBL] [Abstract][Full Text] [Related]
19. Ether derivatives of 3-amino-1,2-propanediols, VI. Syntheses and pharmacological investigations of 5,8-bis-[2-hydroxy-3-(alkylamino)propoxy]-1,4-dihydronaphthalenes.
Chalina E; Christova K; Dantchev D; Staneva D; Rainova L; Chakarova L
Arch Pharm (Weinheim); 1987 Jul; 320(7):655-9. PubMed ID: 2890335
[No Abstract] [Full Text] [Related]
20. N-substituted 2-amino-1-(2-thienyl)ethanols as beta-adrenergic blocking agents.
Corral C; Darias V; Fernández-Tomé MP; Madroñero R; Del Río J
J Med Chem; 1973 Aug; 16(8):882-5. PubMed ID: 4147684
[No Abstract] [Full Text] [Related]
[Next] [New Search]
